心力衰竭:机械学的见解和精确的治疗策略
Fang Zhang1, Xiang Zhang1, Jing Jian1
1Department of Cardiology, Chongzhou People's Hospital, Chongzhou, Sichuan, China.
Frontiers in cardiovascular medicine
|December 22, 2025
概括
心力衰竭 (HF) 的治疗是有限的,特别是在具有保留喷射分数 (HFpEF) 的HF. 新的分子标和个性化策略为改善心力衰竭管理和患者结果提供了希望.
科学领域:
- 心脏病学和分子医学.
- 专注于心力衰竭的病理生理学和新的治疗策略.
背景情况:
- 心力衰竭 (HF) 是一个严重的全球健康负担,患病率,死亡率和经济成本都很高.
- 目前的治疗方法有效性有限,特别是在心力衰竭中,心力衰竭的喷射分数被保存 (HFpEF).
- 肝炎的发病过程涉及复杂的相互作用,包括神经激素激活,代谢功能障碍,炎症和纤维化.
研究的目的:
- 审查了解高频机制的最新进展.
- 探索新兴的治疗标和个性化治疗策略,以治疗HF.
- 强调将研究转化为临床实践的挑战和未来方向.
主要方法:
- 对HF分子和细胞通路的最新科学发现的审查.
- 对新药学药剂,代谢调节剂,基于设备的干预措施和再生医学的分析.
- 检查个性化的方法,包括多omics,生物标志物和AI在HF管理.
主要成果:
- 确定了新的分子和细胞点,用于更精确的高频疗法.
- 新兴的治疗方法包括新药,代谢调节器,设备和再生方法.
- 个性化策略,如多omics和AI显示风险预测和量身定制的护理的承诺.
结论:
- 将机制性见解转化为对高强度肺炎的临床益处仍然是一个重大挑战.
- 未来的研究必须将分子理解与临床表型结合起来,用于精确的HF治疗.
- 加强对这些进展的理解和应用对于改善心力衰竭患者的治疗结果至关重要.
相关概念视频
01:30Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
01:22Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
01:29Cardiomyopathy V: Interprofessional Care
313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
01:29Heart Failure II: Pathophysiology
668
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K